10 May 2021 : Clinical Research
Type of Necrosis Influences Prognosis in Hepatocellular Carcinoma After the First Transarterial Chemoembolization
Zhi-Juan Wu1BCDE, Yin-Fa Xie2B, Xu Chang2BCD, Lin Zhang2AE*, Hui-Yong Wu2B, Ji-Bing Liu2B, Jian-Xin Zhang2C, Peng Sun2CDOI: 10.12659/MSM.929884
Med Sci Monit 2021; 27:e929884
Table 3 Comparison of the prognosis for the coagulative necrosis and liquefactive necrosis groups.
| Coagulative necrosis group (months) (median±SD) | Liquefactive necrosis group (months) (median±SD) | P value | |
|---|---|---|---|
| Overall survival | 23.27±1.40 | 8.83±2.15 | 0.004 |
| Progression-free survival | 9.33±0.96 | 3.70±0.44 | 0.002 |
| Intrahepatic in situ progression | 12.23±1.74 | 5.53±1.29 | 0.008 |
| New intrahepatic metastasis | 14.33±1.32 | 7.20±0.66 | 0.009 |
| Extrahepatic progression | 15.27±3.24 | 6.67±1.29 | 0.011 |
| SD – standard deviation. | |||